ProfileGDS2244 / 220235_s_at
TitleMelanoma cell line response to E2F-1 overexpression and doxorubicin treatment
OrganismHomo sapiens


E2F-1 doxorubicin E2F-1 and doxorubicin GSM52504 GSM52508 GSM52518 GSM52519 GSM52516 GSM52517 65% 68% 73% 73% 65% 72% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM52504SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 1)83.965
GSM52508SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 2)102.568
GSM52518SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 1)142.873
GSM52519SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 2)132.973
GSM52516SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2 plus doxorubicin (sample 1)8365
GSM52517SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2 plus doxorubicin (sample 2)127.272